NCT06354270View on ClinicalTrials.gov

A Clinical Study to Evaluate the Anti-Sensitivity Efficacy of a Stannous Fluoride Toothpaste in a Population of Dentin Hypersensitivity Sufferers

NACompletedINTERVENTIONAL

Enrollment

115

Participants

Timeline

Start Date

April 11, 2024

Primary Completion Date

June 23, 2024

Study Completion Date

June 23, 2024

Conditions

Dentin Sensitivity

Interventions

DRUG

Stannous fluoride toothpaste

Toothpaste containing 0.454 % weight/weight (w/w) SnF2.

DRUG

Regular fluoride toothpaste (Crest Cavity Protection)

Regular fluoride toothpaste containing 1100 parts per million (ppm) fluoride.

Trial Locations (1)

32940

Family and Cosmetic Dentistry, All Sums Research Center Ltd., Melbourne

All Listed Sponsors

lead

HALEON

INDUSTRY

NCT06354270 - A Clinical Study to Evaluate the Anti-Sensitivity Efficacy of a Stannous Fluoride Toothpaste in a Population of Dentin Hypersensitivity Sufferers | Biotech Hunter | Biotech Hunter